Raleigh Capital Management Inc. Grows Stake in iShares U.S. Pharmaceuticals ETF $IHE

Raleigh Capital Management Inc. grew its stake in shares of iShares U.S. Pharmaceuticals ETF (NYSEARCA:IHE) by 865,800.0% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 8,659 shares of the company’s stock after acquiring an additional 8,658 shares during the quarter. Raleigh Capital Management Inc. owned about 0.08% of iShares U.S. Pharmaceuticals ETF worth $751,000 as of its most recent SEC filing.

Several other large investors have also recently modified their holdings of IHE. Hudock Inc. grew its position in iShares U.S. Pharmaceuticals ETF by 3.9% during the 4th quarter. Hudock Inc. now owns 3,034 shares of the company’s stock valued at $257,000 after purchasing an additional 114 shares during the last quarter. O Shaughnessy Asset Management LLC raised its holdings in iShares U.S. Pharmaceuticals ETF by 35.0% in the fourth quarter. O Shaughnessy Asset Management LLC now owns 463 shares of the company’s stock worth $39,000 after buying an additional 120 shares during the last quarter. National Bank of Canada FI lifted its stake in shares of iShares U.S. Pharmaceuticals ETF by 42.7% in the third quarter. National Bank of Canada FI now owns 585 shares of the company’s stock worth $42,000 after buying an additional 175 shares in the last quarter. Root Financial Partners LLC lifted its stake in shares of iShares U.S. Pharmaceuticals ETF by 36.5% in the first quarter. Root Financial Partners LLC now owns 696 shares of the company’s stock worth $60,000 after buying an additional 186 shares in the last quarter. Finally, Corient Private Wealth LLC grew its holdings in shares of iShares U.S. Pharmaceuticals ETF by 3.1% during the fourth quarter. Corient Private Wealth LLC now owns 6,506 shares of the company’s stock valued at $552,000 after buying an additional 198 shares during the last quarter.

iShares U.S. Pharmaceuticals ETF Price Performance

Shares of IHE opened at $100.96 on Friday. The company has a market capitalization of $1.17 billion, a P/E ratio of 17.75 and a beta of 0.49. The firm has a 50 day moving average of $91.69 and a 200 day moving average of $88.76. iShares U.S. Pharmaceuticals ETF has a twelve month low of $64.94 and a twelve month high of $100.96.

iShares U.S. Pharmaceuticals ETF Profile

iShares U.S. Pharmaceuticals ETF, formerly iShares Dow Jones U.S. Pharmaceuticals Index Fund (the Fund), is an exchange traded fund. The Fund seeks investment results that correspond generally to the price and yield performance of the Dow Jones U.S. Select Pharmaceuticals Index (the Index). The Index measures the performance of the pharmaceuticals sector of the United States equity market, and includes pharmaceutical companies such as manufacturers of prescription or over-the-counter drugs or vaccines, but excludes producers of vitamins.